Search Images Maps Play YouTube News Gmail Drive More »
My library | Help | Advanced Book Search | Web History | Sign in

Books

Science lessons:

what the business of biotech taught me about management
Front Cover
2 Reviews
Harvard Business Press, Apr 1, 2008 - Biography & Autobiography - 292 pages
Widely regarded as the most innovative, successful biotech firm ever, Amgen led its industry in revenue and sales growth in 2007. Top magazines including Fortune and Industry Week have repeatedly named it one of America's best companies to work for.

In Science Lessons, Gordon Binder--CEO and chairman during 1988-2000--describes Amgen's climb to success. Revealing the highs and lows it experienced in the race to develop blockbuster drugs, he takes readers from the time Amgen had just three months of capital in the bank and no viable products in the pipeline to its spectacular success. The turning point? The 1989 launch of Epogen, which dramatically helped kidney dialysis patients suffering from debilitating anemia. Other landmark drugs, including Neupogen, would follow.

Through engaging anecdotes and cogent insights, Binder weaves a fascinating tale while offering his unique brand of practical management advice. Using the principals of the scientific method, he shares his recommendations for tackling pressing business challenges--such as managing creative employees, navigating the IPO process, and protecting intellectual property.

This colorful first-person account showcases the visionary science and daring business strategy that made Amgen great--offering valuable lessons for all companies.

From inside the book

What people are saying - Write a review

Review: Science Lessons: What the Business of Biotech Taught Me About Management

User Review  - getAbstract - Goodreads

Intriguing business-focused history of biotech giant Amgen Former Amgen CEO Gordon Binder recounts his biotech company's history in clear, articulate prose. He and writer Philip Bashe make the science ... Read full review

Review: Science Lessons: What the Business of Biotech Taught Me About Management

User Review  - Gil - Goodreads

[Insert clever one-liner glowing with praise]. [Now insert second clever one-liner glowing with praise]. [And a third]. I liked this book. Gordon Binder's tenure of CEO took a large startup and ... Read full review

Related books

Contents

Introduction
1
The Start of a StartUp
17
Amgen Goes Public
39
Copyright

11 other sections not shown

Common terms and phrases

About the author (2008)

Peter Teeley, who served as press secretary to Vice President George Bush, was diagnosed with stage III colon cancer in 1991, and attributes his recovery to the fact that he gained access to a state-of-the-art clinical trial at Georgetown University's Lombardi Cancer Center. He lives in Washington, D.C.
Philip Bashe has written or cowritten seventeen titles spanning several genres, including health and self-help, parenting, sports, biography, autobiography, and popular culture. He lives in Baldwin, New York, with his wife, author Patricia Romanowski Bashe, and their son, Justin.